Bartlett & Co. LLC boosted its position in shares of Corteva, Inc. (NYSE:CTVA) by 24.7% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,939 shares of the company’s stock after purchasing an additional 780 shares during the quarter. Bartlett & Co. LLC’s holdings in Corteva were worth $184,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently made changes to their positions in the company. Sterling Financial Planning Inc. acquired a new stake in Corteva during the 4th quarter worth about $25,000. Concord Wealth Partners purchased a new stake in Corteva during the 4th quarter worth approximately $25,000. Montag A & Associates Inc. purchased a new stake in Corteva during the 4th quarter worth approximately $27,000. ADE LLC acquired a new position in shares of Corteva during the 4th quarter worth approximately $27,000. Finally, Childress Capital Advisors LLC acquired a new position in shares of Corteva during the 4th quarter worth approximately $28,000. Institutional investors and hedge funds own 77.15% of the company’s stock.
Shares of CTVA stock opened at $48.08 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.26 and a current ratio of 1.82. Corteva, Inc. has a 52 week low of $22.38 and a 52 week high of $48.87. The company has a market capitalization of $35.61 billion, a P/E ratio of 58.63, a price-to-earnings-growth ratio of 1.90 and a beta of 0.82. The company’s 50 day moving average price is $46.77 and its two-hundred day moving average price is $40.92.
A number of research firms have commented on CTVA. UBS Group upped their price target on Corteva from $44.00 to $48.00 and gave the stock a “buy” rating in a research note on Thursday, February 4th. Redburn Partners downgraded shares of Corteva from a “buy” rating to a “neutral” rating in a research note on Thursday, January 21st. JPMorgan Chase & Co. upgraded shares of Corteva from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $32.00 to $51.00 in a research note on Friday, February 5th. Loop Capital upgraded shares of Corteva from a “hold” rating to a “buy” rating and set a $54.00 price objective for the company in a research report on Monday. Finally, KeyCorp increased their target price on shares of Corteva from $51.00 to $53.00 and gave the company an “overweight” rating in a report on Monday. Three analysts have rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the company. Corteva has an average rating of “Hold” and a consensus target price of $43.76.
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.